Please ensure Javascript is enabled for purposes of website accessibility

Monsanto Rounds Up Growth

By Brian Orelli, PhD – Updated Apr 5, 2017 at 9:23PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Corn prices spur growth, but the long-term growth is pegged to new seed traits.

There's nothing like the threat of $100 oil to spur the revenue of agricultural giant Monsanto (NYSE: MON), but I'm not sure that's what investors should be focused on.

Sales grew 36% year over year to $2.1 billion for the company's fiscal first quarter. Most of the top-line growth was thanks to increased sales of Roundup, although corn seed sales were also on the rise. Since sales growth significantly outpaced costs, the bottom line looked even better, with diluted EPS nearly tripling.

Oil prices have pushed up the demand for biofuels and production in Brazil, where Monsanto has about 80% of the corn seed market. The planting of additional acres clearly helped Monsanto this quarter, but it also bodes well for rivals Syngenta (NYSE: SYT) and BASF, and even for fertilizer producer Potash (NYSE: POT).

Even with its 55% growth in herbicide sales, Monsanto isn't resting on its laurels -- and for good reason. Roundup sales are directly tied to the amount of acres planted. On the other hand, the amount the company can charge farmers for seeds is tied to the yield the seeds produce. By creating seeds with new traits -- decent yields even in the face of drought and disease, or higher-oil-content soybeans, for example -- it should be able to increase revenue faster than the number of planted acres increases.

The bottom line is that while the hoopla about oil prices and biofuels will drive Monsanto's growth in the short term, long-term growth will be tied to the scientists, not the oil traders.

More green Foolishness:

Help us in our goal to give every young person around the globe a financial education! Learn more about the new direction of Foolanthropy, now in its second decade, here.

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Monsanto Company Stock Quote
Monsanto Company
MON
Nutrien Stock Quote
Nutrien
POT

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.